- Application for Temporary Registration of Pharmacist with Pharmacy Board of Malaysia
- List of Training Premises for Provisionally Registered Pharmacist (PRP)
- Psoriasis Medication Therapy Adherence Clinic (MTAC) Protocol Third Edition
- Obstetrics & Gynaecology Ward Pharmacy Services Protocol
- Thalassaemia Medication Therapy Adherence Clinic (TMTAC) Protocol
You are here
Formulari Ubat KKM (FUKKM)
| # | Generic Name | MDC | Category | Indications | Pres. Restrictions | Dosage |
|---|---|---|---|---|---|---|
| 1 | Oseltamivir 60mg/5ml oral suspension. | J05AH02-000-L80-01-XXX | A/KK | i) For treatment of patients with suspected or confirmed influenza and severe disease (requiring hospitalization or evidence of lower respiratory tract infection). ii) For treatment of patients with suspected or confirmed influenza and with co-morbidity and associated with increased risk of influenza complications. Not to be used as prophylaxis. | None | Children ≥ 1 year (for 5 days): a) ≤15 kg: 30mg twice daily b) >15kg to 23kg:45mg twice daily c) >23kg to 40kg: 60mg twice daily Children with body weight more than 40kg who are able to swallow capsule is recommended to be dosed as adults. |
| 2 | Oseltamivir 75mg capsule. | J05AH02-000-C10-01-XXX | A/KK | i) For treatment of patients with suspected or confirmed influenza and severe disease (requiring hospitalization or evidence of lower respiratory tract infection). ii) For treatment of patients with suspected or confirmed influenza and with co-morbidity and associated with increased risk of influenza complications. Not to be used as prophylaxis. | None | Recommended dose in adults and adolescents ≥ 13 years of age and body weight >40kg is 75mg twice daily for 5 days. Dosing adjustment for renal impaired patient, follow manufacturer's recommendations in product insert. |